1.
Nicolini FE, Khoury HJ, Akard L, Rea D, Kantarjian H, Baccarani M, Leonoudakis J, Craig A, Benichou A-C, Cortes J. Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors. Haematologica [Internet]. 2013Jun.30 [cited 2026Nov.17];98(7):e78-e79. Available from: https://haematologica.org/article/view/6737